Apheresis for Cardiovascular Diseases
Brief History of Low-density Lipoprotein Apheresis
Low-density Lipoprotein Apheresis
The HELP System for the Treatment of Atherothrombotic Disorders
Long-term Effect of Low-density Lipoprotein Apheresis in Patients with Homozygous Familial Hypercholesterolemia
Long-term Effect of Low-density Lipoprotein Apheresis in Patients with Heterozygous Familial Hypercholesterolemia
Low-density Lipoprotein Apheresis in the Prevention of Recurrent Coronary Heart Disease
Low-density Lipoprotein Apheresis in the Treatment of Peripheral Arterial Disease
Changes in Oxidative Stress and Microcirculation by Low-density Lipoprotein Apheresis
The Effect of Apheresis on Adhesion Molecules
Changes in C-reactive Protein Plasma Levels During Low-density Lipoprotein Apheresis
Apheresis in the Treatment of Cholesterol Embolic Disease
Hypercholesterolemic Valvulopathy
Rheopheresis in Patients with Ischemic Diabetic Foot Syndrome
The Sequential Organ Failure Assessment Score as a Useful Predictor for Estimating the Prognosis of Systemic Inflammatory Response Syndrome Patients Being Treated with Extracorporeal Blood Purification
Oxygen Uptake Efficiency Slope as Monitoring Tool for Physical Training in Chronic Hemodialysis Patients
A Case of Advanced Primary Biliary Cirrhosis Treated with Granulocyte and Monocyte Apheresis1